Zobrazeno 1 - 10
of 4 062
pro vyhledávání: ''
Autor:
Julia Nazco-Casariego, Laura Ramos, Fernando Gutiérrez-Nicolás, Raquel De La Barreda, Enrique Quintero, Inmaculada Alonso-Abreu, Javier Ramos-Rodríguez, Marta Carrillo-Palau
Publikováno v:
Gastroenterología y Hepatología (English Edition). 45:335-341
Nonadherence to medication is common in patients with inflammatory bowel disease (IBD) and can result in disease complications, therapy escalation, and the need for corticosteroids. The aim of this study was to assess the adherence to self-administer
Autor:
Benjamin Chaigne, Mickael Martin, Bénédicte Watelet, Elisabeth Diot, Claire Le Jeunne, François Maurier, Jérémie Dion, Luc Mouthon, Cloé Giret, Jean François Viallard, Sabine Berthier, Pascal Priollet, Marie-Elise Truchetet, Alain Lescoat, Olivier Cerles, Dorothée Fagedet, Cyril Cosse, Loic Raffray, Brigitte Granel, Christelle Nguyen, J. Bertolino, Ségolène Toquet, Solen Kernéis, David Luque Paz, Wendy Jourde, Christian Agard, Grégory Pugnet
Publikováno v:
Arthritis Care & Research. 74:809-817
Systemic sclerosis (SSc) is an autoimmune connective tissue disorder characterized by skin fibrosis, vasculopathy, and dysimmunity. Data regarding osteitis in SSc are scarce.We performed a nationwide multicenter, retrospective, case-control study inc
Autor:
Nilay Shah, Lindsey R. Sangaralingham, Parambir S. Dulai, Herbert C. Heien, William J. Sandborn, Jeph Herrin, Siddharth Singh
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 2
Clin Gastroenterol Hepatol
Clin Gastroenterol Hepatol
Background and Aims We conducted a retrospective cohort study comparing the risk of serious infections between patients treated with tumor necrosis factor-a (TNFa) antagonists vs. vedolizumab in patients with inflammatory bowel diseases (IBD). Method
Autor:
Yiran Zhang, Satimai Aniwan, A Weiss, Gursimran Kochhar, Sunanda V. Kane, Bo Shen, Matthew Bohm, Siddharth Singh, Eugenia Shmidt, Jean-Frederic Colombel, Corey A. Siegel, David Faleck, Edward V. Loftus, James P. Campbell, Mahmoud A. Rahal, Siri Kadire, Ronghui Xu, William J. Sandborn, David Hudesman, Arun Swaminath, Joseph Meserve, Robert Hirten, Vipul Jairath, Ryan C. Ungaro, Bruce E. Sands, Karen Lasch, Jenna L. Koliani-Pace, Brigid S. Boland, Parambir S. Dulai, Dana J. Lukin, Shreya Chablaney, Monika Fischer, Adam Winters, Gloria Tran, Shannon Chang, Sashidhar Varma
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Background & Aims We aimed to compare safety and effectiveness of vedolizumab to tumor necrosis factor (TNF)-antagonist therapy in ulcerative colitis in routine practice. Methods A multicenter, retrospective, observational cohort study (May 2014 to D
Autor:
Bei Zhang, Wenzhuo He, Dongsheng Zhang, Xiuxing Chen, Fenghua Wang, Yixing Wang, Qi Quan, Guifang Guo
Publikováno v:
Current Oncology, Vol 28, Iss 23, Pp 209-219 (2021)
Current Oncology
Volume 28
Issue 1
Pages 23-219
Current Oncology
Volume 28
Issue 1
Pages 23-219
Background: There have not been any head-to-head prospective studies to compare the effects of different chemotherapy regimens as first-line treatments for unresectable pancreatic cancer (UPC). We aimed to compare the effectiveness of nab-paclitaxel
Autor:
Huabin Hu, Weiwei Li, Xiaoyu Xie, Jianxia Li, Miaomiao Ding, Jianwei Zhang, Zehua Wu, Jiayu Ling, Yue Cai, Yanhong Deng
Publikováno v:
Clinical Colorectal Cancer. 20:e240-e248
To evaluate the predictive implications and prognosis of mucinous adenocarcinoma (MAC) in locally advanced rectal cancer (LARC) with intensified neoadjuvant treatment.Individual patient data of LARC patients from 3 prospective clinical trials was ana
Publikováno v:
Clinical Colorectal Cancer. 20:e215-e225
Background Suboptimal completion of chemotherapy, which may involve reduced patient adherence, remains a serious issue and leads to reduced treatment efficacy. This study assessed the completion rates, risk factors for noncompletion, and cost impact
Autor:
Shotaro Suzuki, Hiroko Nagafuchi, Yutaka Goto, Keiichi Sakurai, Yoshioki Yamasaki, Kimito Kawahata, Tomohiko Shibata, Mitsuru Imamura, Takeshi Suzuki
Publikováno v:
Modern Rheumatology. 31:1087-1093
ObjectivesRheumatoid arthritis (RA) in patients undergoing immunosuppressive therapy (IS) is sometimes involved with other iatrogenic immunodeficiency-associated lymphoproliferative disorders (LPD). We aimed to clarify the effects of LPD treatment on
Autor:
Toshihiko Kohashi, Shintaro Kuroda, Hirotaka Tashiro, Ichiro Ohmori, Tomoyuki Abe, Hideki Ohdan, Junko Tanaka, Akihiko Oshita, Koichi Oishi, Tsuyoshi Kobayashi, Takashi Onoe, Yasuhiro Imaoka
Publikováno v:
Surgery. 170:1140-1150
Background Posthepatectomy liver failure is a poor prognostic factor after hepatectomy. Various preventive treatments have been tried; however, there are no clinical trials that use posthepatectomy liver failure as the primary endpoint, and the clini
Autor:
Jean El Cheikh, Iman Abou Dalle, Jeries Kort, Farouk Al Chami, Maya Charafeddine, Haidar El Darsa, Rola El Sayed, Ali Ibrahim, Ali Bazarbachi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:711-719
Background Intensified immunochemotherapy with rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and prednisone (R-ACVBP) improves outcomes in younger adults with diffuse large B-cell lymphomas (DLBCL) compared with R-CHOP. Due to vinde